期刊文献+

低分子肝素体外透黏膜及大鼠口腔给药的研究 被引量:2

Permeability of Low Molecular Weight Heparin through Different Mucosas and Its Buccal Administration in Rats
下载PDF
导出
摘要 采用活化部分凝血活酶时间(APTT)测定低分子肝素(LMWH)透过鸡嗉囊膜、犬口腔、大鼠肠道及口腔等黏膜的透过量,并考察药物浓度、pH、氯化钠浓度和聚乙二醇辛酸/癸酸甘油酯(Labrasol)对其透过的影响。结果表明,Labrasol能促进LMWH透过不同黏膜;LMWH可经大鼠口腔黏膜吸收进入体循环。 The transmucosal cumulative permeation amount of low molecular weight heparin (LMWH) through different kinds of animal mucosa such as chicken crop mucosa, dog buccal mucosa, rat intestinal and buccal mucosa was determined by activated partial thromboplastin time (APTT) method. The influences of the drug concentration, pH, NaCI concentration and Labrasol on permeation amount were investigated. The results showed that Labrasol could increase mucosa permeability of LMWH through the above cited mucosas. After buccal administration of LMWH in rats, the transmucosal absorption was observed.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2009年第9期666-671,共6页 Chinese Journal of Pharmaceuticals
关键词 低分子肝素 鸡嗉囊膜 大鼠肠黏膜 口腔黏膜 活化部分凝血活酶时间 low molecular weight heparin chicken crop mucosa rat intestinal mucosa buccal mucosa activated partial thromboplastin time
  • 相关文献

参考文献9

  • 1Lamprecht A, Ubrich N, Maincent P. Oral low molecular weight heparin delivery by mieropartieles from complex coacervation [J]. Eur J Pharm Biopharm, 2007, 67 (3) : 632-638.
  • 2臧恒昌,翟光喜.低分子肝素纳米脂质体的制备及家兔鼻腔吸收的研究[J].中国药学杂志,2003,38(3):196-198. 被引量:16
  • 3刘建红,梁大华,梅芬娥,郭炎荣,闭桂莲.不同剂量肝素经肺给药的血药浓度变化[J].中国临床药学杂志,2000,9(6):347-349. 被引量:3
  • 4Hwang KK, Jiang L, Ren Y, et al. Site-specific absorption of M100240 and MDL 100,173 in rats evaluated using Sweetana-Grass diffusion chamber technology [J]. J Pharmacol Toxicol Methods, 2002, 48 (2) : 97-101.
  • 5Ito Y, Murakami A, Maeda T, et al. Evaluation of selfdissolving needles containing low molecular weight heparin (LMWH) in rats [J]. Int JPharm, 2008, 349(1-2): 124-129.
  • 6崔慧斐,李华,李婧.低分子肝素胶囊稳定性的初步研究[J].中国医药工业杂志,1998,29(11):495-497. 被引量:3
  • 7Yu SY, Zhao Y, Zhang Q, et al. Nasal insulin delivery in the chitosan solution: in vitro and in vivo studies [J]. lnt J Pharm, 2004, 281 (1-2) : 11-23.
  • 8Chiou WL, Barve A. Linear correlation of the fraction of oral dose absorbed of 64 drugs between humans and rats [J]. Pharm Res, 1998, 15 (11) : 1792-1795.
  • 9Koga K, Kawashima S, Murakami M. In vitro and in situ evidence for the contribution of Labrasol and Gelucire 44/14 on transport of cephalexin and cefoperazone by rat intestine [J]. Eur J Pharm Biopharm, 2002, 54 (3) : 311-318.

二级参考文献10

共引文献19

同被引文献67

  • 1谢继青,牛爱军,方喜峰,程霞,张妍,喻学红.低分子肝素舌下含片处方筛选及其药效观察[J].中国医院药学杂志,2004,24(10):590-592. 被引量:5
  • 2戚平平,李冰,徐建华,张贵君,刘成桂.消心痛喷雾剂治疗冠心病的血液动力学变化[J].实用心电学杂志,2005,14(2):113-114. 被引量:1
  • 3徐红,席晓岚.派罗宁B褪色光度法测微量肝素[J].化学与生物工程,2006,23(2):57-59. 被引量:2
  • 4沈腾,徐惠南,翁伟宇,张建芳,高璇.低分子肝素肠道吸收促进剂的研究[J].中国药学杂志,2006,41(3):206-210. 被引量:5
  • 5徐红,刘绍璞,罗红群,席晓岚.硫堇褪色光度法测定微量肝素[J].理化检验(化学分册),2006,42(10):829-831. 被引量:1
  • 6Kim SK, Lee EH, Vaishali B, et al.Tricaprylin microemulsion for oral delivery of low molecular weight heparin conjugates[J]. J Control Release, 2005, 105 (1-2) : 32-42.
  • 7Hoffart V, Lamprecht A, Maincent P, et al. Oral bioavailability of a low molecular weight heparin using a polymeric delivery system [J]. J Control Release, 2006, 113 (1) : 38-42.
  • 8Arnold J, Ahsan F, Meezan E, Pillion DJ, et al. Nasal administration of low molecular weight heparin [J]. J Pharm Sci, 2002, 91 (7): 1707-1714.
  • 9Yang T, Hussain A, Paulson J, et al. Cyclodextrins in nasal delivery of low-molecular-weight heparins: in vivo and in vitro studies [J]. Pharm Res, 2004, 21 (7) : 1127-1136.
  • 10Yang T, Mustafa F, Ahsan F. Alkanoylsucroscs in nasal delivery of low molecularweight heparins: in-vivo absoinption and reversibility studies in rats [J]. J Pharm Pharmacol, 2004, 56(1): 53-60.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部